Article Information
History
- March 3, 2021.
Article Versions
- Version 1 (September 16, 2019 - 15:14).
- Version 2 (September 16, 2019 - 21:32).
- Version 3 (September 17, 2019 - 19:01).
- Version 4 (June 2, 2020 - 23:25).
- You are currently viewing Version 5 of this article (March 3, 2021 - 07:04).
- View Version 6, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Han-Soo Kim1,2,*,
- Moon Kee Meang3,*,
- Saesbyeol Kim3,
- Ji Yong Lee4,
- Baik L. Seong5,
- Ik-Hwan Kim6 and
- Byung-Soo Youn3,#
- 1Department of Biomedical Sciences, Catholic Kwandong University College of Medical Convergence, Gangneung-si, Gangwon-do 25601, Republic of Korea
- 2Basic Research Division, Biomedical Institute of Mycological Resource, College of Medicine, Catholic Kwandong University, Gangneung-si, Gangwon-do 25601, Republic of Korea
- 3Osteoneurogen, Inc., Seoul, 08501, Republic of Korea
- 4Research Institute of Hyperbaric Medicine and Science, Yonsei University Wonju College of Medicine, Wonju-si, Gangwon-do 26426, Republic of Korea
- 5Department of Biotechnology, Yonsei University, Seoul 03722, Republic of Korea
- 6Department of Biotechnology, Korea University, Seoul 02841, Republic of Korea
- ↵#Corresponding author, E-mail address: byung4jc{at}gmail.com
↵* These authors contributed equally.
Posted March 03, 2021.
Discovery of a small molecule having both potent anti-fibrotic and anti-inflammatory capabilities
